BridgeMD
New treatment option for Hypertrophic Cardiomyopathy
Official title Comparison of the Effects of Inspiratory Muscle Training and Baduanjin Exercises in Hypertrophic Cardiomyopathy Patients
ClinicalTrials.gov ID: NCT06490250
What this study is testing
- What it's testing
- The study aims to compare the effects of inspiratory muscle training and Baduanjin exercises on pulmonary function, exercise capacity, and quality of life in patients with hypertrophic cardiomyopathy. By investigating these interventions, the investigators seek to introduce novel approaches that can enhance pulmonary function, exercise capacity, and overall quality of life for these patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Myocardial thickness in any region of the left ventricle is 15 mm or more on echocardiography or cardiac MRI
- Clinically and hemodynamically stable (patients with NYHA Class I and II)
- Patients over 18 years of age
- Patients who provide informed consent
You likely can't join if
- Acute decompensated heart failure
- Decreased ejection fraction (\<40%)
- Unstable angina pectoris
- Significant coronary artery disease (CAD)
- Severe renal dysfunction (estimated glomerular filtration rate \<30 mL/min/m²)
- Uncontrolled hypertension (despite medication)
See the full eligibility criteria
- Myocardial thickness in any region of the left ventricle is 15 mm or more on echocardiography or cardiac MRI
- Clinically and hemodynamically stable (patients with NYHA Class I and II)
- Patients over 18 years of age
- Patients who provide informed consent
- Acute decompensated heart failure
- Decreased ejection fraction (\<40%)
- Unstable angina pectoris
- Significant coronary artery disease (CAD)
- Severe renal dysfunction (estimated glomerular filtration rate \<30 mL/min/m²)
- Uncontrolled hypertension (despite medication)
- Severe valve disease (moderate-severe aortic stenosis, advanced mitral regurgitation)
- Severe neurological disorders causing autonomic dysfunction
- Cognitive impairment that prevents communication
- Recent fractures, osteoporosis, presence of tumors, pregnancy, or back and spine problems
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.